3-Reagent Homocysteine Assay for SYNCHRON UniCel - The 3-Reagent Homocysteine Assay for SYNCHRON - AXIS-SHIELD DIAGNOSTICS LIMITED

Duns Number:229062427

Device Description: The 3-Reagent Homocysteine Assay for SYNCHRON UniCel DxC System is intended for in vitro q The 3-Reagent Homocysteine Assay for SYNCHRON UniCel DxC System is intended for in vitro quantitative determination of total homocysteine in human serum and plasma. The device can assist in the diagnosis and treatment of patients suspected of having hyperhomocysteinemia and homocystinuria.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

FHYB100/B08175

Brand Name

3-Reagent Homocysteine Assay for SYNCHRON UniCel

Version/Model Number

FHYB100/B08175

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

-

Prescription Use (Rx)

-

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

K112790

Product Code Details

Product Code

LPS

Product Code Name

Urinary Homocystine (Nonquantitative) Test System

Device Record Status

Public Device Record Key

1bde5089-8078-4b71-ac31-a1fd040ef599

Public Version Date

July 06, 2018

Public Version Number

3

DI Record Publish Date

July 01, 2016

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"AXIS-SHIELD DIAGNOSTICS LIMITED" Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 2
2 A medical device with a moderate to high risk that requires special controls. 6